-
Recently, there have been frequent changes in senior management of multinational pharmaceutical companies
Time of Update: 2022-10-31
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
-
New drug for ulcerative colitis (UC)! Oral S1P receptor modulator Zeposia: with continuous treatment for 1 year, the disease has no recurrence rate of 86.1%!
Time of Update: 2022-10-31
October 25, 2022 /BioValleyBIOON/ -- Bristol-Myers Squibb (BMS) has unveiled new post-hoc analysis data from the anti-inflammatory drug Zeposia (ozanimod) in the treatment of moderately to severely active ulcerative colitis (UC) Phase 3 True North (NCT02435992) at the annual scientific meeting of the American Society of Gastroenterology (ACG).
-
During the disclosure period of the third quarterly report, the performance of the two major sectors of the pharmaceutical industry was eye-catching
Time of Update: 2022-10-31
As of October 26, Wind data shows that a total of 141 A-share biopharmaceutical companies have disclosed three quarterly reports, of which 84 companies have achieved a year-on-year increase in net profit attributable to the parent in the first three quarters, accounting for 59.
-
During the disclosure period of the third quarterly report, the performance of the two major sectors of the pharmaceutical industry was eye-catching
Time of Update: 2022-10-31
As of October 26, Wind data shows that a total of 141 A-share biopharmaceutical companies have disclosed three quarterly reports, of which 84 companies have achieved a year-on-year increase in net profit attributable to the parent in the first three quarters, accounting for 59.
-
Practice the evaluation indicators of high-quality development of public hospitals and continuously improve the capacity of medical services
Time of Update: 2022-10-31
In order to explore the path of improving medical service capacity, and at the same time grasp the opportunities of rapid digital development and promote the high-quality development of hospitals, Xinhuanet, together with Zhejiang Provincial People's Hospital and GlaxoSmithKline, a public welfare supporter, recently launched the 2022 National Hospital Presidents Salon of "Continuously Improving Medical Service Capabilities and Digitally Empowering High-quality Development of Hospitals", inviting ten public hospital leaders to have in-depth exchanges.
-
Johnson & Johnson 2022Q3: blockbuster products face patent cliff, ibrutinib is "besieged"
Time of Update: 2022-10-31
Sales of ustekinumab, a blockbuster product in the field of self-exemption, exceeded $2 billion, but the patent cliff is coming In the third quarter, Johnson & Johnson's self-immunity revenue was $4.
-
Local pharmaceutical companies are innovating, and the competition for talents has been surging
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; In recent years, with the promotion of the new medical reform policy, the domestic pharmaceutical industry has gradually upgraded from generic drugs to innovative drugs, and local pharmaceutical companies have accelerated the pace of innovation and transformation.
-
Recently, a large number of domestic and foreign pharmaceutical companies have chosen to jointly develop new drugs
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; In order to accelerate innovation and commercialize products, strong alliances between pharmaceutical companies have become the norm in the industry in recent years.
js?cdnversion='+~(-new Date()/36e5)]; In order to accelerate innovation and commercialize products, strong alliances between pharmaceutical companies have become the norm in the industry in recent years.
-
Piperine 95% 98% 10% Black Piperine Extract Industry News
Time of Update: 2022-10-31
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
-
The new version of the "Measures for the Administration of Drug Recalls" came into force on November 1
Time of Update: 2022-10-31
On October 26, the State Food and Drug Administration issued a newly revised "Measures for the Administration of Drug Recalls" (hereinafter referred to as the "Measures"), which will come into effect
-
In order to expand the pharmaceutical territory, this CRO company intends to initiate an acquisition!
Time of Update: 2022-10-31
Considering that both parties control the company by the same actual controller, since 2016, according to the company's overall strategic plan, all drug research and development service business has been carried out by Sunshine Novo, and Langyan Life is only used as an investment management platform and is no longer engaged in drug research and development service business.
-
In order to enhance competitiveness, pharmaceutical machinery enterprises are accelerating the extension of the industrial chain layout
Time of Update: 2022-10-31
It is understood that in addition to the above-mentioned enterprises, since the beginning of this year, many pharmaceutical companies have also issued announcements such as acquisitions and cooperation, all of which are aimed at promoting the extended layout of the industrial chain and improving the productivity and market competitiveness of enterprises.
-
Under the tide of "slimming" in the pharmaceutical industry, the medical equipment manufacturer will lay off nearly 4,000 employees
Time of Update: 2022-10-31
On October 24, Philips, a Dutch medical device manufacturer, announced urgent actions to improve performance, including immediate layoffs of about 4,000 employees worldwide and an expected charge of about 300 million euros in the coming quarters.
-
Pharmacopoeia Commission: More than 300 varieties [identification] items involve deletion!
Time of Update: 2022-10-31
Source: Pharmacopoeia Commission: wangxinglai2004 On October 27, 2022, the State Pharmacopoeia Commission issued the Notice on the Announcement of the Draft Revision of the National Standard for the
-
Traditional Chinese medicine formula granules will open up a market of 100 billion yuan in the future, and this industry may follow the "light"
Time of Update: 2022-10-31
Formulated granules will open up a market of 100 billion It is understood that since November 2021, Chinese medicine formula granules have begun to switch to the new national standard, gradually upgrading to provincial standards and national standards, and this year has also been in the national standard switching period, but the implementation progress of traditional Chinese medicine formula granules in various places is different, resulting in different filing progress.
-
Policy interpretation of the Administrative Measures for Drug Recalls
Time of Update: 2022-10-31
Drug recall refers to the activity of the holder to withdraw drugs that have quality problems or other potential safety hazards on the market in accordance with the prescribed procedures, and take corresponding measures to control risks and eliminate hidden dangers in a timely manner.
-
The selection of the ninth batch of excellent domestic medical equipment product catalogue was launched
Time of Update: 2022-10-31
Recently, the China Medical Equipment Association issued the "Announcement on Launching the Selection of the Ninth Batch of Excellent Domestic Medical Equipment Product Catalog". The ninth batch of e
-
Chongqing Matjiang: Improve the service system of traditional Chinese medicine to make "minor diseases not leave home"
Time of Update: 2022-10-31
the Health Commissionmedicinal materials Wang Tao said in an interview with a reporter from China News Network that the next step will continue to promote Chinese medicine culture into campuses, communities, institutions, townships and enterprises, so that the cause of traditional Chinese medicine can be carried forward in inheritance and developed in innovation.
-
The sword refers to Merck Prevymis, Nanjing Chia Tai Tianqing Class 4 generic drug "Letemovir Tablets" reported production
Time of Update: 2022-10-31
Since 2017, Temovir tablets and intravenous formulations have been approved by the FDA for use in adult recipients of CMV-seropositive allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the prevention of CMV infection, and the trade name is Prevymis.
-
Dynamic analysis of Xi'an ferulic acid 98% fine powder rice bran extract supply industry
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; Dynamic Analysis of Xi'an Ferulic Acid 98% Fine Powder Rice Bran Extract Supply Industry 1.
js?cdnversion='+~(-new Date()/36e5)]; Dynamic Analysis of Xi'an Ferulic Acid 98% Fine Powder Rice Bran Extract Supply Industry 1.
